Vernessa Pollard

Vernessa Pollard advises life sciences, medical device, and technology companies, helping them navigate US Food and Drug Administration (FDA) regulatory and compliance issues to bring novel technologies and cutting-edge products to market. As a trusted advisor and legal strategist for multi-national life science companies, start-ups, and investors, Vernessa helps clients develop practical, scalable, and innovative strategies for solving challenging regulatory and compliance problems – evaluating risk and achieving business objectives.

For medical device, technology, and biotech companies, she provides strategic business and regulatory counsel regarding premarket strategy, including product development, post-market compliance, and regulatory matters that range from manufacturing and quality to advertising and promotion.

Vernessa previously served as Associate Chief Counsel for Enforcement in the FDA's Office of Chief Counsel, where she represented the FDA on a variety of regulatory, litigation and enforcement matters involving issues ranging from advertising, medical device and drug manufacturing to clinical trial compliance and product safety. She worked closely with compliance and regulatory personnel across FDA, including FDA's Center for Devices and Radiology Health (CDRH), to review and evaluate warning letters, compliance policies and regulatory actions.